These results indicate compromised Th-1 responses in IPF patients after BNT162b2 vaccination and possibly impaired protection in this group as reduced IFNγ secretion has been connected with attenuated humoral responses to mRNA COVID-19 vaccines (40). The gene discussed is NELFCD; the disease is COVID-19.